$3.65
-0.015-0.41%
Last update: Nov 6, 4:50 PM
Arbutus Biopharma Corp
ABUSNASDAQ
Arbutus Biopharma (ABUS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.03 | $-0.03 | 0.00 % |
| Q1 | May 13, 2026 | $0.87 | $-0.06 | 1550.0 % |
| Q4 | Mar 23, 2026 | $-0.01 | $-0.04 | 75.0 % |
| Q3 | Nov 13, 2025 | $-0.04 | $-0.04 | 0.00 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $1.01M | $961.00K | 5.52 % |
| Q1 | May 13, 2026 | $179.13M | $1.53M | 11599.9 % |
| Q4 | Mar 23, 2026 | $1.05M | $829.00K | 26.8 % |
| Q3 | Nov 13, 2025 | $529.00K | $1.31M | -59.6 % |
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.06 | $-0.04 | $-0.04 |
| Actual | $-0.03 | $0.87 | $-0.01 | $-0.04 |
| Surprise | 0.00% | +1550.0% | +75.0% | 0.00% |
| Revenue | ||||
| Estimate | $961000 | $1.5M | $829000 | $1.3M |
| Actual | $1.0M | $179.1M | $1.1M | $529000 |
| Surprise | +5.52% | +11599.9% | +26.8% | -59.6% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.03 | $-0.03 |
| Revenue | ||
| Consensus | $1.4M | $1.4M |
